Fredrikson welcomes back attorney Alexander Rosenstein as an officer in its Corporate, Corporate Governance, Finance & Securities, Life Sciences and Public Companies & Capital Markets groups.
Rosenstein has extensive experience advising clients on corporate governance, securities, capital markets and corporate development matters. Rosenstein previously practiced at Fredrikson from 2005 to 2014.
Prior to rejoining Fredrikson, Rosenstein was the General Counsel and Corporate Secretary of Cardiovascular Systems, Inc., a Nasdaq-listed medical device company, until its acquisition by Abbott Laboratories in 2023.
Fredrikson & Byron is a leading Midwest law firm working collaboratively to help businesses achieve their goals regionally, nationally and globally. With a reputation as the firm “where law and business meet,” our attorneys bring business acumen and entrepreneurial thinking to work with clients and operate as business advisors and strategic partners as well as legal counselors. The firm’s 375+ attorneys are based in Minneapolis, with offices in Ames, Bismarck, Des Moines, Fargo, Madison, Mankato, St. Paul, Saltillo, Mexico, and Shanghai, China. Learn more at fredlaw.com, or LinkedIn.